FDA Investigator: Lakshmi Ran Narasimhan
- Lakshmi Ran Narasimhan first started conducting FDA inspections in 2012, with the last inspection in 2018. Over that time, Lakshmi Ran Narasimhan has conducted 7 inspections at 7 companies across 6 sites.
Documents
FDA 483 Intas Biopharmaceuticals, Ahmedabad | July 2015
Available - $199
Lakshmi Ran Narasimhan
Human Drug Form 483
FDA 483 Exelead, Inc., Indianapolis | 2018
Out-of-stock
Lakshmi Ran Narasimhan
Human Drug Form 483
FDA 483 Biocon Limited, Bangalore | 2017
Out-of-stock
Lakshmi Ran Narasimhan
Human Drug Form 483
FDA 483 Eli Lilly SA Irish Branch, Kinsale, County Cork | 2014
Out-of-stock
Lakshmi Ran Narasimhan
Human Drug Form 483
FDA 483 Sigma-Tau Pharmasource, Inc., Indianapolis | 2013
Out-of-stock
Lakshmi Ran Narasimhan
Human Drug Form 483
FDA 483 Novartis Pharmaceuticals Corporation, Vacaville | 2012
Out-of-stock
Lakshmi Ran Narasimhan
Human Drug Form 483
Co-Investigators (15)
- Bo Chi, FDA Investigator
- Jazmine N. Still, FDA Investigator
- Lindsey J. Brown, FDA Investigator
- Michael Shanks, FDA Investigator
- Reyes Candau-Chacon, FDA Investigator
- Daniel J. Roberts, FDA Investigator
- Kalavati C. Suvarna, FDA Investigator
- Meisha R. Waters, FDA Investigator
- Larry K. Austin, FDA Investigator
- Colleen Thomas, FDA Investigator
- Meisha R. Sampson, FDA Investigator
- Patricia F. Hughes Troost, FDA Investigator
- Lance M. De Souza, FDA Investigator
- Hughes Troost, Patricia F, FDA Investigator
- De Souza, Lance M, FDA Investigator